Skip Navigation
Skip to contents

Int J Stem Cells.  2023 Feb;16(1):27-35. 10.15283/ijsc22110.

Inhibition of Class I Histone Deacetylase Enhances Self-Reprogramming of Spermatogonial Stem Cells into Pluripotent Stem Cells

Affiliations
  • 1Department of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea
  • 2Center for Stem Cell Research, Institute of Advanced Biomedical Science, Konkuk University, Seoul, Korea
  • 3Research Institute of Medical Science, Konkuk University, Seoul, Korea

Abstract

Background and Objectives
Spermatogonial stem cells (SSCs) are the most primitive cells in spermatogenesis and are the only adult stem cells capable of passing on the genome of a given species to the next generation. SSCs are the only adult stem cells known to exhibit high Oct4 expression and can be induced to self-reprogram into pluripotent cells depending on culture conditions. Epigenetic modulation is well known to be involved in the induction of pluripotency of somatic cells. However, epigenetic modulation in self-reprogramming of SSCs into pluripotent cells has not been studied.
Methods and Results
In this study, we examined the involvement of epigenetic modulation by assessing whether selfreprogramming of SSCs is enhanced by treatment with epigenetic modulators. We found that second-generation selective class I HDAC inhibitors increased SSC reprogramming efficiency, whereas non-selective HDAC inhibitors had no effect.
Conclusions
We showed that pluripotent stem cells derived from adult SSCs by treatment with small molecules with epigenetic modulator functions exhibit pluripotency in vitro and in vivo. Our results suggest that the mechanism of SSC reprogramming by epigenetic modulator can be used for important applications in epigenetic reprogramming research.

Keyword

SSCs; Spermatogonial stem cells; HDAC inhibitor; Epigenetic modulator; Epigenetic reprogramming; Self-re- programming
Full Text Links
  • IJSC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr